Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Emerg Infect Dis. 2003 Jun;9(6):730-3.

    Fluoroquinolone use and Clostridium difficile-associated diarrhea.

    Source

    University of Maryland, Baltimore, Maryland, USA.

    Abstract

    We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile-associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confidence interval 2.6 to 61.6) was the strongest risk factor for CDAD.

    PMID:
    12781017
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3000134
    Free PMC Article

      Supplemental Content

      Icon for CDC-NCEZID Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk